AccessibilityHelp
Canopy Growth logo

Canopy Growth(NASDAQ) CGC

Market Cap$279.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-98%
5 Year-100%
1 Year-50%
1 Month-31%
Premium Feature
Moneyball Superscore
35/100
$0.67
+1.10%
+0.01Today
After hours$0.67-$0.00 (-0.21%)
Canopy Growth last closing stock price
MetricPriceDate
Last closeUSD 0.672026-10-22
Canopy Growth stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-9.54%USD 0.742026-10-15
1 month-31.21%USD 0.972026-09-22
3 month-25.13%USD 0.892026-07-24
Year to date-41.64%USD 1.142025-12-31
1 year-49.6%USD 1.322025-10-22
3 year-86.88%USD 5.072023-10-23
5 year-99.5%USD 133.802021-10-22
Since inception-97.98%USD 33.002014-04-07

Canopy Growth Financials at a Glance

Market Cap

$279.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$321.37M

Net Income (TTM)

-CA$259.27M

EPS (TTM)

-$0.45

P/E Ratio

-1.47

Dividend

$0.00

Beta (Volatility)

1.98 (High)

Price

$0.67

Volume

1,863,080

Open

$0.68

Previous Close

$0.68

Daily Range

$0.65 - $0.68

52-Week Range

$0.65 - $2.38

Estimated Earnings Date

Nov 6, 2026

CGC News

GettyImages-1477090373-1300x867-43e2dcf

Trump's Marijuana Order Is Stuck at the DEA. Here's What That Means for Canopy Growth.

Thomas NielOct 18, 2026
A person in a greenhouse Getty Images..jpg

Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?

Sara AppinoOct 15, 2026
Cannabis greenhouse.

How to Buy Canopy Growth Stock (CGC) in 2026

Jeremy BowmanOct 13, 2026
Person in lab gear working with marijuana plants.jpg

Canopy Growth vs. Tilray Brands: Which Healthcare Stock Is a Better Buy in 2026?

Sarah SidlowOct 10, 2026
A person examining a cannabis plant Getty Images..jpg

Can Canopy Growth Survive Another 5 Years?

David Jagielski, CPAOct 6, 2026
Cannabis Commercial Weed Bud Grown on Plant Under Warehouse Lights Getty

Canopy Growth Is Closing in on Positive EBITDA. Should You Buy the Stock?

Jeff SiegelSep 30, 2026
22_09_29 A person looking at a laptop raising their arms as if frustrated _GettyImages-1359039717_MF Dload

Canopy Growth Is Eyeing Another Reverse Stock Split. Will It Be Enough to Light a Fire Beneath the Beaten-Down Pot Stock?

Reuben Gregg BrewerSep 23, 2026
GettyImages-1477090373-1200x800-5b2df79

Canopy Growth's Business Is Improving. So Why Isn't the Stock Performing Better?

Thomas NielSep 14, 2026
Page 1

CGC: Motley Fool Moneyball Superscore

35

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Canopy Growth

Canopy Growth Corporation NASDAQ:CGC helps people find relief using cannabis. It makes products for medical and recreational needs. The company serves customers in Canada and Germany.

What Is in the Stash?

  • Cannabis Segment: Diverse range of flower, oils, and edibles for various consumer uses.
  • Storz & Bickel: High-end vaporizer devices manufactured with rigorous safety and performance certifications.
  • Adult-Use Brands: Consumer labels like Tweed and 7ACRES serving the Canadian adult market.
  • Medical Services: Network of clinics providing cannabis access to patients across Canada and internationally.

Cultivating New Markets

  • Acquired MTL Cannabis Corp. on March 16, 2026, to expand cultivation genetic capabilities.
  • Established Canopy USA in Oct. 2022 to prepare for United States market entry.
  • Finalized the acquisition of Acreage Holdings on Dec. 9, 2024, to build U.S. presence.
  • Expanded international medical sales into Germany and Poland during the first quarter of fiscal 2027.

A Different Kind of Greenhouse

Canopy Growth uses an asset-right model that focuses on driving efficiency through regional partnerships. This approach limits direct ownership of facilities to lower fixed costs and improve returns.

Measuring the Harvest

  • Net revenue was $81.2 million in the first quarter of fiscal 2027, up 13% year over year.
  • Net loss narrowed to $14.6 million in the first quarter of fiscal 2027.
  • Gross margin reached 27% in the first quarter of fiscal 2027, up from 25% year over year.
  • Cash and cash equivalents totaled $336.6 million as of June 30, 2026.

The Final Word

Canopy Growth has evolved from a broad producer into a focused brand house with a leaner operating structure. The company maintains its position in Canada while building a strategic bridge to the United States market.

AI Generated • Aug 7, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

1,128

CEO

Luc Mongeau

Website

www.canopygrowth.com

Headquarters

Smiths Falls, ON K7A 0A8, CA

CGC Financials

Key Financial Metrics (TTM)

Gross Margin

22.87%

Operating Margin

-46.89%

Net Income Margin

-73.95%

Return on Equity

-29.85%

Return on Capital

-7.49%

Return on Assets

-21.43%

Earnings Yield

-68.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$279.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

419.57M

Volume

1.86M

Avg. Volume

2.96M

Financials (TTM)

Gross Profit

CA$81.86M

Operating Income

-CA$102.63M

EBITDA

-CA$191.50M

Operating Cash Flow

-CA$78.48M

Capital Expenditure

-CA$5.20M

Free Cash Flow

-CA$83.68M

Cash & ST Invst.

CA$341.68M

Total Debt

CA$277.33M

Canopy Growth Performance Analysis

Canopy Growth annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31CAD 251,914,041-38.1%
20242024-03-31CAD 220,299,074-12.5%
20252025-03-31CAD 193,391,074-12.2%
20262026-03-31CAD 205,921,2766.5%
Canopy Growth sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30-7.6%
Q32025-12-3153.4%
Q42026-03-31-30.3%
Q12026-06-3013.9%
Canopy Growth annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31CAD -53.44745.7%
20242024-03-31CAD -6.52-87.8%
20252025-03-31CAD -3.40-47.8%
20262026-03-31CAD -0.64-81.2%
Canopy Growth sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-3097.3%
Q32025-12-31-4066.7%
Q42026-03-31-60.0%
Q12026-06-3092.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

CA$81.17M

+12.5%

Gross Profit

CA$22.24M

+23.3%

Gross Margin

27.40%

N/A

Market Cap

$279.14MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$247.46K

N/A

Employees

1,128

N/A

Net Income

-CA$14.58M

+64.9%

EBITDA

-CA$4.67M

+78.6%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

CA$341.68M

+137.9%

Total Debt

CA$277.33M

-15.4%

Accounts Receivable

CA$42.59M

-14.9%

Inventory

CA$107.46M

+14.5%

Long Term Debt

CA$234.26M

-24.2%

Short Term Debt

CA$43.07M

+127.6%

Return on Assets

-21.43%

N/A

Return on Invested Capital

-16.01%

N/A

Free Cash Flow

-CA$25.75M

-117.7%

Operating Cash Flow

-CA$25.01M

-142.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CABACabaletta Bio, Inc.
$1.47-3.29%
ACBAurora Cannabis Inc.
$3.88-2.27%
LFCRLifecore Biomedical, Inc.
$6.40+0.47%
LYELLyell Immunopharma, Inc.
$9.39+0.11%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$147.49+1.89%
TAT&T
$20.93-7.96%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$83.56+1.77%
NUNu Holdings
$15.16+2.92%

Questions About CGC

What is the current price of Canopy Growth?

Canopy Growth is trading at $0.68 per share.

What is the 52-week range for Canopy Growth?

Over the past 52 weeks, Canopy Growth has traded between $0.65 and $2.38.

How much debt does Canopy Growth have?

As of the most recent reporting period, Canopy Growth reported total debt of CA$195.47M.

How much cash does Canopy Growth have on hand?

Canopy Growth reported CA$237.27M in cash and cash equivalents in its most recent financial results.

What is Canopy Growth’s dividend yield?

Canopy Growth does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services